Gossamer Bio, Inc. — Form D

Gossamer Bio, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-18. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Joshua Bilenker, M.D.DirectorSan Diego, CA
Laura Carter, Ph.D.Executive OfficerSan Diego, CA
Richard LimDirectorBOSTON, MA
Robert NelsenDirectorSeattle, WA
Kristina BurowDirectorSan Diego, CA
FAHEEM HASNAINDirectorSAN DIEGO, CA
FAHEEM HASNAINExecutive OfficerSAN DIEGO, CA
Sandra Milligan, M.D., J.D.DirectorSan Diego, CA
Russell CoxDirectorSan Diego, CA
Bryan GiraudoExecutive OfficerSan Diego, CA
Richard Aranda, M.D.Executive OfficerSan Diego, CA
Renee GalaDirectorSan Diego, CA
Caryn PetersonExecutive OfficerSan Diego, CA
Thomas Daniel, M.D.DirectorSan Diego, CA
Christian WaageExecutive OfficerSan Diego, CA
Michael YiDirectorSouth San Francisco, CA
Jill HoweExecutive OfficerSan Diego, CA
Sheila Gujrathi, M.D.DirectorSan Diego, CA
Sheila Gujrathi, M.D.Executive OfficerSan Diego, CA
Otello Stampacchia, Ph.D.DirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-08-07D$212.1M$212.1M
2018-08-01D$230.0M$230.0M
2018-01-19D$80.0M$70.5M
2018-01-19D$80.0M$70.5M

More